Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-002591

Intra-Cellular Therapies, Inc. · ITCI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Robert E Davis
Officer — SVP, Chief Scientific Officer
Period of report
Jan 3, 2018
Accepted (ET)
Jan 5, 2018 · 8:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567514

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Jan 3, 2018M2,648—A30,512D
Common StockJan 4, 2018S1,115$15.60D29,397D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF3,F4—Jan 3, 2018M2,648D——Common Stock2,6485,298D
Stock Option (right to buy)F5$15.47Jan 3, 2018A65,164A—Jan 3, 2028Common Stock65,16465,164D
Restricted Stock UnitsF3,F6—Jan 3, 2018A48,480A——Common Stock48,48048,480D

Explanation of responses